Additionally, COVID-19-related disproportion in CD4+ and CD8+ T lymphocytes led to increases in the NLR value, which was reported to be a more sensitive biomarker of inflammation than the individual levels of neutrophils and lymphocytes [23]. This evidence concerns the gene CD4 and COVID-19.